It can take 10-15 years to develop a new medicine at an estimated cost of £1.2bn
At the Medicines Discovery Catapult we aim to help UK SME biotechs, academics and innovators have access to the laboratory facilities, knowledge, data, technologies and networks they need to be able to progress their programmes of medicines research and development. Our objective is to work collaboratively as part of a Syndicate to bring new proven therapies to patients faster and more cost-effectively.
Latest News
Psychiatry Consortium brings Charles River Laboratories and Evotec on board
World-leading drug discovery organisations Charles River Laboratories and Evotec join the Psychiatry Consortium as drug discovery and development partners. The two organisations bring invaluable expertise
LUNAC Therapeutics led project awarded £3.14 million under Innovate UK Biomedical Catalyst programme, to develop next-generation anticoagulant
Today (2nd December 2019) LUNAC Therapeutics (LUNAC), a UK based drug discovery company focused on the identification and development of advanced anticoagulants with minimal bleeding
Medicines Discovery Catapult finalist for the Bionow Technical Service Award
Yesterday (28th November 2019) Medicines Discovery Catapult (MDC) was recognised at the Bionow Annual Awards 2019, being a finalist for the Bionow Technical Service Award